Skip to content

Clinical trials

Schizophrenia trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Sweden Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20053
20073
20082
20091
20103
20114
20121
20141
20161
20211
20223
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated5
Recruiting3
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen-Cilag International NV4
AstraZeneca3
Boehringer Ingelheim2
Denovo Biopharma LLC2
Hoffmann-La Roche2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Uppsala University2
Eli Lilly and Company1
Göteborg University1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia28
Psychotic Disorders6
Mental Disorders2
Anhedonia1
Autistic Disorder1
Bipolar Disorder1
Obsessive-Compulsive Disorder1
Schizophrenia Spectrum and Other Psychotic Disorders1
Schizophrenia, Paranoid1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.